GlassScriptPhysician profile
Gary Haber
NPI 1417996653
$1,645.03
in general payments reported to CMS, 2019-2025
13 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $80.61 · 2021: $161 · 2022: $189 · 2023: $580 · 2024: $69.77 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $874.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $548.46 | 2023-2025 | Sprint Pns System |
| Boston Scientific Corporation | $357.96 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $161.84 | 2019-2024 | Proclaim |
| Curonix LLC | $137.25 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $119.04 | 2019 | |
| Medtronic, INC. | $116.49 | 2021-2024 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.47 | 2021-2022 | |
| Nevro Corp. | $39.79 | 2019 | |
| Collegium Pharmaceutical, INC. | $32.92 | 2019-2023 | Belbuca |
| Abbvie INC. | $25.30 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $20.49 | 2024 | Iovera, Zilretta |
| Grt US Holding, INC. | $18.92 | 2021 | |
| Pfizer INC. | $16.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Haber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.